Brokerages Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) Target Price at $18.89

Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Samsara (NYSE:IOT) Downgraded by StockNews.com to “Sell”
Next post Gladstone Land Co. Announces Monthly Dividend of $0.13 (NASDAQ:LANDP)